Metisergida (Spanish Wikipedia)

Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 677-. ISBN 978-3-88763-075-1.
Ritter, James M.; Flower, Rod J.; Henderson, Graeme; Rang, H. P.; MD, Yoon Kong Loke, MB Bs MRCP; MacEwan, David (14 de febrero de 2020). Rang Y Dale. Farmacología. Elsevier Health Sciences. p. 221-224. ISBN 978-84-9113-644-6. Consultado el 9 de junio de 2023.
Fernández, Pedro Lorenzo (2 de marzo de 2015). Velázquez. Farmacología Básica y Clínica. Ed. Médica Panamericana. p. 483. ISBN 978-84-9835-481-2. Consultado el 9 de junio de 2023.
Sacks, Oliver (18 de abril de 2006). Migraña. Anagrama. p. 344. ISBN 978-84-339-4204-3. Consultado el 8 de junio de 2023.
Receptor - Based Drug Design. CRC Press. 10 de abril de 1998. pp. 181-182. ISBN 978-1-4200-0113-6.
Titus, Feliu; Rosich, Patricia Pozo (23 de agosto de 2022). La Migraña: Aprende a prevenirla, a entender sus factores desencadenantes y cómo tratarla. Editorial AMAT. p. 107. ISBN 978-84-19341-26-6. Consultado el 9 de junio de 2023.

doi.org (Global: 2^nd place; Spanish: 2^nd place)

dx.doi.org

Methysergide (en inglés). Elsevier. 2016. pp. 973-974. ISBN 978-0-444-53716-4. doi:10.1016/b978-0-444-53717-1.01070-2. Consultado el 9 de junio de 2023.
Ramírez Rosas MB, Labruijere S, Villalón CM, Maassen Vandenbrink A (August 2013). «Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs». Expert Opinion on Pharmacotherapy 14 (12): 1599-1610. PMID 23815106. doi:10.1517/14656566.2013.806487.
Joseph T, Tam SK, Kamat BR, Mangion JR (April 2003). «Successful repair of aortic and mitral incompetence induced by methylsergide maleate: confirmation by intraoperative transesophageal echocardiography». Echocardiography 20 (3): 283-287. PMID 12848667. doi:10.1046/j.1540-8175.2003.03027.x.
Silberstein SD (September 1998). «Methysergide». Cephalalgia 18 (7): 421-435. PMID 9793694. doi:10.1046/j.1468-2982.1998.1807421.x.
Diamond, Seymour; Urban, George (2007). Cluster Headache (en inglés). Elsevier. pp. 474-491. ISBN 978-0-7216-0334-6. doi:10.1016/b978-0-7216-0334-6.50048-0. Consultado el 9 de junio de 2023.
Colpaert FC, Niemegeers CJ, Janssen PA (October 1979). «In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists». European Journal of Pharmacology 58 (4): 505-509. PMID 510385. doi:10.1016/0014-2999(79)90326-1.
Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (August 2004). «Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors». Naunyn-Schmiedeberg's Archives of Pharmacology 370 (2): 114-123. PMID 15322733. doi:10.1007/s00210-004-0951-4.
Bredberg U, Eyjolfsdottir GS, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V (1 de enero de 1986). «Pharmacokinetics of methysergide and its metabolite methylergometrine in man». European Journal of Clinical Pharmacology 30 (1): 75-77. PMID 3709634. doi:10.1007/BF00614199.
«Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea». Medicinal Plants and Fungi: Recent Advances in Research and Development. Medicinal and Aromatic Plants of the World 4. 2017. pp. 229-252. ISBN 978-981-10-5977-3. ISSN 2352-6831. doi:10.1007/978-981-10-5978-0_8.
Ott J, Neely P (1980). «Entheogenic (hallucinogenic) effects of methylergonovine». Journal of Psychedelic Drugs 12 (2): 165-166. PMID 7420432. doi:10.1080/02791072.1980.10471568.
«Serotonin and serotonin receptors in hallucinogen action». Handbook of the Behavioral Neurobiology of Serotonin. Handbook of Behavioral Neuroscience 31. 2020. pp. 843-863. ISBN 9780444641250. ISSN 1569-7339. doi:10.1016/B978-0-444-64125-0.00043-8.
Cavero I, Guillon JM (2014). «Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy». Journal of Pharmacological and Toxicological Methods 69 (2): 150-161. PMID 24361689. doi:10.1016/j.vascn.2013.12.004.
Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL (December 2000). «Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications». Circulation 102 (23): 2836-2841. PMID 11104741. doi:10.1161/01.cir.102.23.2836.
Dahlöf, Carl; Maassen Van Den Brink, Antoinette (2012-04). «Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment». Headache 52 (4): 707-714. ISSN 1526-4610. PMID 22444161. doi:10.1111/j.1526-4610.2012.02124.x. Consultado el 7 de junio de 2023.
Newman-Tancredi, A.; Conte, C.; Chaput, C.; Verrièle, L.; Audinot-Bouchez, V.; Lochon, S.; Lavielle, G.; Millan, M. J. (1997-06). «Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy». Naunyn-Schmiedeberg's Archives of Pharmacology 355 (6): 682-688. ISSN 0028-1298. PMID 9205951. doi:10.1007/pl00005000. Consultado el 7 de junio de 2023.
Koehler PJ, Tfelt-Hansen PC (November 2008). «History of methysergide in migraine». Cephalalgia 28 (11): 1126-1135. PMID 18644039. doi:10.1111/j.1468-2982.2008.01648.x.
1966 Webb AJ, Edwards PD (April 1966). «Methysergide and Retroperitoneal Fibrosis.». British Medical Journal 1 (5495): 1110. PMC 1844020. doi:10.1136/bmj.1.5495.1110-a.
Graham JR, Suby HI, LeCompte PR, Sadowsky NL (February 1966). «Fibrotic disorders associated with methysergide therapy for headache». The New England Journal of Medicine 274 (7): 359-368. PMID 5903120. doi:10.1056/NEJM196602172740701.

drugpatentwatch.com (Global: low place; Spanish: low place)

«Sansert / methysergide maleate FDA New drug application 012516 international drug patent coverage, generic alternatives and suppliers». DrugPatentWatch (en inglés). Consultado el 6 de septiembre de 2017.

elsevier.com (Global: 610^th place; Spanish: 332^nd place)

linkinghub.elsevier.com

Methysergide (en inglés). Elsevier. 2016. pp. 973-974. ISBN 978-0-444-53716-4. doi:10.1016/b978-0-444-53717-1.01070-2. Consultado el 9 de junio de 2023.
Diamond, Seymour; Urban, George (2007). Cluster Headache (en inglés). Elsevier. pp. 474-491. ISBN 978-0-7216-0334-6. doi:10.1016/b978-0-7216-0334-6.50048-0. Consultado el 9 de junio de 2023.

europa.eu (Global: 68^th place; Spanish: 91^st place)

ema.europa.eu

«Restricciones de uso de los medicamentos que contienen metisergida». European Medicines Agency. 28 de abril de 2014. Consultado el 8 de junio de 2023.
«CHMP referral assessment report».

issn.org (Global: 57^th place; Spanish: 3^rd place)

portal.issn.org

«Multipotent and Poly-therapeutic Fungal Alkaloids of Claviceps purpurea». Medicinal Plants and Fungi: Recent Advances in Research and Development. Medicinal and Aromatic Plants of the World 4. 2017. pp. 229-252. ISBN 978-981-10-5977-3. ISSN 2352-6831. doi:10.1007/978-981-10-5978-0_8.
«Serotonin and serotonin receptors in hallucinogen action». Handbook of the Behavioral Neurobiology of Serotonin. Handbook of Behavioral Neuroscience 31. 2020. pp. 843-863. ISBN 9780444641250. ISSN 1569-7339. doi:10.1016/B978-0-444-64125-0.00043-8.
Dahlöf, Carl; Maassen Van Den Brink, Antoinette (2012-04). «Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment». Headache 52 (4): 707-714. ISSN 1526-4610. PMID 22444161. doi:10.1111/j.1526-4610.2012.02124.x. Consultado el 7 de junio de 2023.
Newman-Tancredi, A.; Conte, C.; Chaput, C.; Verrièle, L.; Audinot-Bouchez, V.; Lochon, S.; Lavielle, G.; Millan, M. J. (1997-06). «Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy». Naunyn-Schmiedeberg's Archives of Pharmacology 355 (6): 682-688. ISSN 0028-1298. PMID 9205951. doi:10.1007/pl00005000. Consultado el 7 de junio de 2023.
Fitzgerald, L. W.; Burn, T. C.; Brown, B. S.; Patterson, J. P.; Corjay, M. H.; Valentine, P. A.; Sun, J. H.; Link, J. R. et al. (2000-01). «Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine». Molecular Pharmacology 57 (1): 75-81. ISSN 0026-895X. PMID 10617681. Consultado el 7 de junio de 2023.

medscape.com (Global: 719^th place; Spanish: 759^th place)

emedicine.medscape.com

«Retroperitoneal Fibrosis Imaging: Overview, Radiography, Computed Tomography». eMedicine. MedScape. 30 de marzo de 2017.

migrainetrust.org (Global: low place; Spanish: low place)

«Methysergide». The Migraine Trust (en inglés británico). Consultado el 6 de septiembre de 2017.

nih.gov (Global: 4^th place; Spanish: 4^th place)

ncbi.nlm.nih.gov

Ramírez Rosas MB, Labruijere S, Villalón CM, Maassen Vandenbrink A (August 2013). «Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs». Expert Opinion on Pharmacotherapy 14 (12): 1599-1610. PMID 23815106. doi:10.1517/14656566.2013.806487.
Joseph T, Tam SK, Kamat BR, Mangion JR (April 2003). «Successful repair of aortic and mitral incompetence induced by methylsergide maleate: confirmation by intraoperative transesophageal echocardiography». Echocardiography 20 (3): 283-287. PMID 12848667. doi:10.1046/j.1540-8175.2003.03027.x.
Silberstein SD (September 1998). «Methysergide». Cephalalgia 18 (7): 421-435. PMID 9793694. doi:10.1046/j.1468-2982.1998.1807421.x.
Saxena PR, Lawang A (October 1985). «A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors». Archives Internationales De Pharmacodynamie Et De Therapie 277 (2): 235-252. PMID 2933009.
Colpaert FC, Niemegeers CJ, Janssen PA (October 1979). «In vivo evidence of partial agonist activity exerted by purported 5-hydroxytryptamine antagonists». European Journal of Pharmacology 58 (4): 505-509. PMID 510385. doi:10.1016/0014-2999(79)90326-1.
Knight AR, Misra A, Quirk K, Benwell K, Revell D, Kennett G, Bickerdike M (August 2004). «Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors». Naunyn-Schmiedeberg's Archives of Pharmacology 370 (2): 114-123. PMID 15322733. doi:10.1007/s00210-004-0951-4.
Bredberg U, Eyjolfsdottir GS, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V (1 de enero de 1986). «Pharmacokinetics of methysergide and its metabolite methylergometrine in man». European Journal of Clinical Pharmacology 30 (1): 75-77. PMID 3709634. doi:10.1007/BF00614199.
Ott J, Neely P (1980). «Entheogenic (hallucinogenic) effects of methylergonovine». Journal of Psychedelic Drugs 12 (2): 165-166. PMID 7420432. doi:10.1080/02791072.1980.10471568.
Cavero I, Guillon JM (2014). «Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy». Journal of Pharmacological and Toxicological Methods 69 (2): 150-161. PMID 24361689. doi:10.1016/j.vascn.2013.12.004.
Rothman RB, Baumann MH, Savage JE, Rauser L, McBride A, Hufeisen SJ, Roth BL (December 2000). «Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications». Circulation 102 (23): 2836-2841. PMID 11104741. doi:10.1161/01.cir.102.23.2836.
Dahlöf, Carl; Maassen Van Den Brink, Antoinette (2012-04). «Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment». Headache 52 (4): 707-714. ISSN 1526-4610. PMID 22444161. doi:10.1111/j.1526-4610.2012.02124.x. Consultado el 7 de junio de 2023.
Newman-Tancredi, A.; Conte, C.; Chaput, C.; Verrièle, L.; Audinot-Bouchez, V.; Lochon, S.; Lavielle, G.; Millan, M. J. (1997-06). «Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy». Naunyn-Schmiedeberg's Archives of Pharmacology 355 (6): 682-688. ISSN 0028-1298. PMID 9205951. doi:10.1007/pl00005000. Consultado el 7 de junio de 2023.
Fitzgerald, L. W.; Burn, T. C.; Brown, B. S.; Patterson, J. P.; Corjay, M. H.; Valentine, P. A.; Sun, J. H.; Link, J. R. et al. (2000-01). «Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine». Molecular Pharmacology 57 (1): 75-81. ISSN 0026-895X. PMID 10617681. Consultado el 7 de junio de 2023.
Koehler PJ, Tfelt-Hansen PC (November 2008). «History of methysergide in migraine». Cephalalgia 28 (11): 1126-1135. PMID 18644039. doi:10.1111/j.1468-2982.2008.01648.x.
1966 Webb AJ, Edwards PD (April 1966). «Methysergide and Retroperitoneal Fibrosis.». British Medical Journal 1 (5495): 1110. PMC 1844020. doi:10.1136/bmj.1.5495.1110-a.
Graham JR, Suby HI, LeCompte PR, Sadowsky NL (February 1966). «Fibrotic disorders associated with methysergide therapy for headache». The New England Journal of Medicine 274 (7): 359-368. PMID 5903120. doi:10.1056/NEJM196602172740701.

pubmed.ncbi.nlm.nih.gov

Dahlöf, Carl; Maassen Van Den Brink, Antoinette (2012-04). «Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment». Headache 52 (4): 707-714. ISSN 1526-4610. PMID 22444161. doi:10.1111/j.1526-4610.2012.02124.x. Consultado el 7 de junio de 2023.
Newman-Tancredi, A.; Conte, C.; Chaput, C.; Verrièle, L.; Audinot-Bouchez, V.; Lochon, S.; Lavielle, G.; Millan, M. J. (1997-06). «Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy». Naunyn-Schmiedeberg's Archives of Pharmacology 355 (6): 682-688. ISSN 0028-1298. PMID 9205951. doi:10.1007/pl00005000. Consultado el 7 de junio de 2023.
Fitzgerald, L. W.; Burn, T. C.; Brown, B. S.; Patterson, J. P.; Corjay, M. H.; Valentine, P. A.; Sun, J. H.; Link, J. R. et al. (2000-01). «Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine». Molecular Pharmacology 57 (1): 75-81. ISSN 0026-895X. PMID 10617681. Consultado el 7 de junio de 2023.

pubchem.ncbi.nlm.nih.gov

«Methysergide». PubChem. U.S. National Library of Medicine.
«methysergide». PubChem (en inglés). U.S. National Library of Medicine. Consultado el 6 de septiembre de 2017.

tranquilene.com (Global: low place; Spanish: low place)

«tranquilene page». Tranquility Labs.

unc.edu (Global: 1,538^th place; Spanish: 1,360^th place)

pdsp.unc.edu

«PDSP Database - UNC». pdsp.unc.edu. Archivado desde el original el 14 de abril de 2021. Consultado el 15 de enero de 2022.

web.archive.org (Global: 1^st place; Spanish: 1^st place)

«PDSP Database - UNC». pdsp.unc.edu. Archivado desde el original el 14 de abril de 2021. Consultado el 15 de enero de 2022.

xocpharma.com (Global: low place; Spanish: low place)

«Novel Receptor Activity Mapping of Methysergide and its Metabolite, Methylergometrine, Provides a Mechanistic Rationale for both the Clinically Observed Efficacy and Risk of Fibrosis in Patients with Migraine (2663)». Neurology 94 (15 Supplement): 2663. April 2020. Parámetro desconocido |vauthors= ignorado (ayuda)

Metisergida (Spanish Wikipedia)

archive.org (Global: 6th place; Spanish: 5th place)

books.google.com (Global: 3rd place; Spanish: 7th place)

doi.org (Global: 2nd place; Spanish: 2nd place)

dx.doi.org

drugpatentwatch.com (Global: low place; Spanish: low place)

elsevier.com (Global: 610th place; Spanish: 332nd place)

linkinghub.elsevier.com

europa.eu (Global: 68th place; Spanish: 91st place)

ema.europa.eu

issn.org (Global: 57th place; Spanish: 3rd place)

portal.issn.org

medscape.com (Global: 719th place; Spanish: 759th place)

emedicine.medscape.com

migrainetrust.org (Global: low place; Spanish: low place)

nih.gov (Global: 4th place; Spanish: 4th place)

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

pubchem.ncbi.nlm.nih.gov

tranquilene.com (Global: low place; Spanish: low place)

unc.edu (Global: 1,538th place; Spanish: 1,360th place)

pdsp.unc.edu

web.archive.org (Global: 1st place; Spanish: 1st place)

xocpharma.com (Global: low place; Spanish: low place)

archive.org (Global: 6^th place; Spanish: 5^th place)

books.google.com (Global: 3^rd place; Spanish: 7^th place)

doi.org (Global: 2^nd place; Spanish: 2^nd place)

elsevier.com (Global: 610^th place; Spanish: 332^nd place)

europa.eu (Global: 68^th place; Spanish: 91^st place)

issn.org (Global: 57^th place; Spanish: 3^rd place)

medscape.com (Global: 719^th place; Spanish: 759^th place)

nih.gov (Global: 4^th place; Spanish: 4^th place)

unc.edu (Global: 1,538^th place; Spanish: 1,360^th place)

web.archive.org (Global: 1^st place; Spanish: 1^st place)